Kidney cancer cells secrete IL-8 to activate Akt and promote migration of mesenchymal stem cells

Urologic Oncology: Seminars and Original Investigations

Volumn 32, Issue 5, 2014, Pages 607-612

  Liang kuan, Bi ^a   Nan, Zhou ^a   Cheng, Liu ^a   Fu Ding, Lu ^a   Tian Xin, Lin ^a   Xu Jun, Xuan ^a   Chun, Jiang ^a   Jin Li, Han ^a   Hai, Huang ^a   Cai Xia, Zhang ^a   Wen, Dong ^a   Hao, Liu ^a   Jian, Huang ^a   Ke Wei, Xu ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Akt; Extracellular signal regulated protein kinase; Interleukin 8; Kidney cancer; Mesenchymal stem cell

Indexed keywords

CHEMOKINE RECEPTOR CXCR2; INTERLEUKIN 8; PROTEIN KINASE B; IL8 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; KIDNEY CANCER; MALE; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RENAL CANCER CELL LINE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; BLOOD; CELL MOTION; CYTOLOGY; DRUG RESISTANCE; GENE EXPRESSION REGULATION; KIDNEY TUMOR; MESENCHYMAL STROMA CELL; MIDDLE AGED; PHOSPHORYLATION; TUMOR CELL LINE;

ADULT; AGED; CELL LINE, TUMOR; CELL MOVEMENT; DRUG RESISTANCE, NEOPLASM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-8; KIDNEY NEOPLASMS; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 84902550331     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2013.10.018     Document Type: Article

References (22)

1. Kode.J.A., Mukherjee S., Joglekar M.V., Hardikar A.A. Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy 2009, 11:377-391.
2. Augello A., De Bari C. The regulation of differentiation in mesenchymal stem cells. Hum Gene Ther 2010, 21:1226-1238.
3. Chen X., Armstrong M.A., Li G. Mesenchymal stem cells in immunoregulation. Immunol Cell Biol 2006, 84:413-421.
4. Loebinger M.R., Kyrtatos P.G., Turmaine M., Price A.N., Pankhurst Q., M.F.Lythgoe, et al. Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles. Cancer Res 2009, 69:8862-8867.
5. Gao P., Ding Q., Wu Z., Jiang H., Fang Z. Therapeutic potential of human mesenchymal stem cells producing IL-12 in a mouse xenograft model of renal cell carcinoma. Cancer Lett 2010, 290:157-166.
6. Yang X., Hou J., Han Z., Wang Y., Hao C., Wei L., et al. One cell, multiple roles: contribution of mesenchymal stem cells to tumor development in tumor microenvironment. Cell Biosci 2013, 3:5.
7. Li C., Guo S., Shi T. Role of NF-κ-B activation in matrix metalloproteinase 9, vascular endothelial growth factor and interleukin 8 expression and secretion in human breast cancer cells. Cell Biochem Funct 2013, 31:263-268.
8. Kim H., Choi J.A., Park G.S., Kim J.H. BLT2 up-regulates interleukin-8 production and promotes the invasiveness of breast cancer cells. PLoS One 2012, 7:e49186.
9. Bi L.K., Tang B., Zhu B., Xie C.L., Li S.A., Lin T.X., et al. Systemic delivery of IL-10 by bone marrow derived stromal cells has therapeutic benefits in sepsis therapy. Prog Biochem Biophys 2010, 37:678-685.
10. Chavey C., Muehlbauer M., Bossard C., Freund A., Durand S., Jorgensen C., et al. Interleukin-8 expression is regulated by histone deacetylases through the nuclear factor-kappa B pathway in breast cancer. Mol Pharmacol 2008, 74:1359-1366.
11. Waugh D.J.J., Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res 2008, 14:6735-6741.
12. SA Bergfeld, DeClerck Y.A. Bone marrow-derived mesenchymal stem cells and the tumor microenvironment. Cancer Metastasis Rev 2010, 29:249-261.
13. Bulj Z., Duchi S., Bevilacqua A., Gherardi A., Dozza B., Piccinini F., et al. Protein kinase B/AKT isoform 2 drives migration of human mesenchymal stem cells. Int J Oncol 2013, 42:118-126.
14. Rojas M., Xu J., Woods C.R., Mora A.L., Spears W., Roman J., et al. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 2005, 33:145-152.
15. Sato Y., Araki H., Kato J., Nakamura K., Kawano Y., Kobune M., et al. Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood 2005, 106:756-763.
16. Spaeth E., Klopp A., Dembinski J., Andreeff M., Marini F. Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells. Gene Ther 2008, 15:730-738.
17. Kidd S., Spaeth E., Watson K., Burks J., Lu H., Klopp A., et al. Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma. PLoS One 2012, 7:e30563.
18. Pasquet M., Golzio M., Mery E., Rafii A., Benabbou N., Mirshahi P., et al. Hospicells (ascites-derived stromal cells) promote tumorigenicity and angiogenesis. Int J Cancer 2010, 126:2090-2101.
19. Patel S.A., Meyer J.R., Greco S.J., Corcoran K.E., Bryan M., Rameshwar P. Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta. J Immunol 2010, 184:5885-5894.
20. Brat D.J., Bellail A.C., Van Meir E.G. The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neurol Oncol 2005, 7:122-133.
21. Schraufstatter I.U., Chung J., Burger M. IL-8 activates endothelial cell CXCR1 and CXCR2 through Rho and Rac signaling pathways. Am J Physiol Lung Cell Mol Physiol 2001, 280:L1094-L1103.
22. Ryu C.H., Park S.A., Kim S.M., Lim J.Y., Jeong C.H., Jun J.A., et al. Migration of human umbilical cord blood mesenchymal stem cells mediated by stromal cell-derived factor-1/CXCR4 axis via Akt, ERK, and p38 signal transduction pathways. Biochem Biophys Res Commun 2010, 398:105-110.